Calcium Regulation, Calcium Homeostasis, and Genetic Disorders of Calcium Metabolism

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 1, Issue , 2010, Pages 1136-1159

  Thakker, Rajesh V ^a   Bringhurst, F Richard ^b,c   Jüppner, Harald ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85153822688     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00060-5     Document Type: Chapter

References (342)

1. SM Krane (1970) Calcium, phosphate and magnesium. H Rasmussen,(Eds) The International Encyclopedia of Pharmacology and Therapeutics London: Pergamon Press 19.
2. R Neer, M Berman, L Fisher, et al. (1967) Multicompartmental analysis of calcium kinetics in normal adult males. J Clin Invest 46 1364-1379.
3. MK Glimcher and SM Krane (1968) Organization and structure of bone and the mechanism of calcification. BS Gould, GN Ramachandran,(Eds) Treatise on collagen, Part B New York: Academic Press 68-241.
4. CW Carr (1955) Electrochemistry in biology and medicine. New York: John Wiley and Sons
5. GN Bowers, C Brassard and SF Sena (1986) Measurement of ionized calcium in serum with ion-selective electrodes: a mature technology that can meet the daily service needs. Clin Chem 32 1437-1447.
6. S Krabbe, I Transbol and C Christiansen (1982) Bone mineral homeostasis, bone growth, and mineralization during years of pubertal growth: a unifying concept. Arch Dis Child 57 359-363.
7. RM Pitkin, WA Reynolds, GA Williams, et al. (1979) Calcium metabolism in normal pregnancy: a longitudinal study. Am J Obstet 133 781-790.
8. JM Gertner, OR Coustan, AS Kliger, et al. (1986) Pregnancy as a state of physiologic absorptive hypercalcemia. Am J Med 81 451-456.
9. GB Forbes (1976) Calcium accumulation by the human fetus. Pediatrics 57 976-977.
10. RM Pitkin, DP Cruikshank, CW Schauberger, et al. (1980) Fetal calciotropic hormones and neonatal calcium homeostasis. Pediatrics 66 77-82.
11. L Hillman, S Sateesha, M Haussler, et al. (1981) Control of mineral homeostasis during lactation: interrelationships of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, 1,25-dihydroxyvitamin, parathyroid hormone, calcitonin, prolactin, and estradiol. Am J Obstet Gynecol 139 471-476.
12. FR Greer, RC Tasang, JE Searcy, et al. (1982) Mineral homeostasis during lactation-relationship to serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone, and calcitonin. Am J Clin Nutr 36 431-437.
13. GJ Barritt (1999) Receptor-activated Ca2+ inflow in animal cells: a variety of pathways tailored to meet different intracellular Ca2+ signalling requirements. Biochem J 337 153-169.
14. MJ Berridge (1997) Elementary and global aspects of calcium signaling. J Physiol 499 291-306.
15. E Carafoli (1987) Intracellular calcium homeostasis. Ann Rev Biochem 56 395-433.
16. H Rasmussen and PQ Barrett (1984) Calcium messenger system: An integrated view. Physiol Rev 64 938-984.
17. E Brown, A Pollack and S Hebert (1998) The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med 49 15-29.
18. H Rasmussen (1986) The calcium messenger system. N Engl J Med 314 1094-1101.
19. RP Heaney, JC Gallagher, CC Johnston, et al. (1982) Calcium nutrition and bone health in the elderly. Am J Clin Nutr 36 986-1013.
20. LH Allen (1982) Calcium bioavailability and absorption: a review. Am J Clin Nutr 35 783-808.
21. LV Avioli, JE McDonald and SW Lee (1965) Influence of aging on the intestinal absorption of 47-Ca in women and its relation to 47-Ca absorption in postmenopausal osteoporosis. J Clin Invest 44 1960-1967.
22. P Ireland and JS Fordtran (1973) Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J Clin Invest 52 2672-2681.
23. JC Gallagher, BL Riggs, J Eisman, et al. (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J Clin Invest 64 729-736.
24. RP Heaney and TG Skillman (1964) Secretion and excretion of calcium by the human gastrointestinal tract. J Lab Clin Med 64 29-41.
25. GA Rose, GW Reed and AH Smith (1965) Isotopic method for measurement of calcium absorption from the gastrointestinal tract. Br Med J 1 690-692.
26. J Phang, M Berman and G Finerman (1969) Dietary perturbation of calcium metabolism in normal man: compartmental analysis. J Clin Invest 48 67-77.
27. A Jung, P Bartholdi and B Mermillod (1978) Critical analysis of methods of analyzing human calcium kinetics. J Theor Biol 73 131-157.
28. JS Fordtran and TW Locklear (1966) Ionic constituents and osmolality of gastric and small-intestinal fluids after eating. Am J Dig Dis 11 503-521.
29. F Bronner, D Pansu and WD Stein (1986) An analysis of intestinal calcium transport across the rat intestine. Am J Physiol 250 G561-G569.
30. CS Marcus and FW Lengemann (1962) Absorption of Ca45 and Sr85 from solid and liquid food at various levels of the alimentary tract of the rat. J Nutr 77 155-160.
31. J Birge, WA Peck, M Berman, et al. (1969) Study of calcium absorption in man: a kinetic analysis and physiologic model. J Clin Invest 48 1705-1713.
32. P Dano and C Christiansen (1974) Calcium absorption and bone mineral content following intestinal shunt operations for obesity: a comparison of three types of procedures. Scand J Gastroenterol 9 775-779.
33. JG Hoenderop, AW van der Kemp, A Hartog, et al. (1999) Molecular identification of the apical Ca2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem 274 8375-8378.
34. JB Peng, XZ Chen, UV Berger, et al. (1999) Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 274 22739-22746.
35. R Vennekens, J Prenen, JG Hoenderop, et al. (2001) Pore properties and ionic block of the rabbit epithelial calcium channel expressed in HEK 293 cells. J Physiol 530 183-191.
36. MJ Gunthorpe, CD Benham, A Randall, et al. (2002) The diversity in the vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol Sci 23 183-191.
37. B Nilius, R Vennekens, J Prenen, et al. (2001) The single pore residue Asp542 determines Ca2+ permeation and Mg2+ block of the epithelial Ca2+ channel. J Biol Chem 276 1020-1025.
38. E den Dekker, JG Hoenderop, B Nilius, et al. (2003) The epithelial calcium channels, TRPV5 & TRPV6: from identification towards regulation. Cell Calcium 33 497-507.
39. L Zhuang, JB Peng, L Tou, et al. (2002) Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest 82 1755-1764.
40. RJ Wood, L Tchack and S Taparia (2001) 1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line. BMC Physiol 1 11.
41. SJ Van Cromphaut, M Dewerchin, JG Hoenderop, et al. (2001) Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A 98 13324-13329.
42. Y Song, S Kato and JC Fleet (2003) Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 133 374-380.
43. SJ Van Cromphaut, K Rummens, I Stockmans, et al. (2003) Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res 18 1725-1736.
44. JJ Feher, CS Fullmer and RH Wasserman (1992) Role of facilitated diffusion of calcium by calbindin in intestinal calcium absorption. Am J Physiol 262 C517-C526.
45. A Ruchon, H Tenenhouse, M Marcinkiewicz, et al. (2000) Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. J Bone Miner Res 15 1440-1450.
46. WE Lassiter, CW Gottschalk and M Mylle (1963) Micropuncture study of renal tubular reabsorption on calcium in normal rodents. Am J Physiol 204 771-775.
47. PA Friedman and FA Gesek (1995) Cellular calcium transport in renal epithelia: measurement, mechanisms, and regulation. Physiol Rev 75 429-471. [Review] [418 refs]
48. JE Bourdeau and MB Burg (1979) Effects of PTH on calcium transport across the cortical thick ascending limb of Henle's loop. Am J Physiol 238 F350.
49. WN Suki, D Rouse, RC Ng, et al. (1980) Calcium transport in the thick ascending limb of Henle: heterogeneity of function in the medullary and cortical segments. J Clin Invest 66 1004-1009.
50. GR Shareghi and ZS Agus (1982) Magnesium transport in the cortical thick ascending limb of Henle's loop of the rabbit. J Clin Invest 69 759.
51. JE Bourdeau and MB Burg (1980) Effect of PTH on calcium transport across the cortical thick ascending limb of Henle's loop. Am J Physiol 239 F121-F126.
52. PA Friedman (1988) Basal and hormone-activated calcium absorption in mouse renal thick ascending limbs. Am J Physiol 254 F62-F70.
53. DB Simon, Y Lu, KA Choate, et al. (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285 103-106.
54. S Weber, K Hoffmann, N Jeck, et al. (2000) Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet 8 414-422.
55. A Blanchard, X Jeunemaitre, P Coudol, et al. (2001) Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59 2206-2215.
56. M Konrad, A Schaller, D Seelow, et al. (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79 949-957.
57. GA Quamme (1982) Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can J Physiol Pharmacol 60 1275-1280.
58. D Riccardi, AE Hall, N Chattopadhyay, et al. (1998) Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol 274 F611-F622.
59. WH Wang, M Lu and SC Hebert (1996) Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. Am J Physiol 271 C103-C111.
60. W Wang, M Lu, M Balazy, et al. (1997) Phospholipase A2 is involved in mediating the effect of extracellular Ca2+ on apical K+ channels in rat TAL. Am J Physiol 273 F421-F429.
61. HI Motoyama and PA Friedman (2002) Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs. Am J Physiol Renal Physiol 283 F399-F406.
62. AJ Barakat and OM Rennert (2001) Gitelman's syndrome (familial hypokalemia-hypomagnesemia). J Nephrol 14 43-47.
63. R Vargas-Poussou, C Huang, P Hulin, et al. (2002) Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 13 2259-2266.
64. ZS Agus, PJS Chiu and M Goldberg (1977) Regulation of urinary calcium excretion in the rat. Am J Physiol 232 F545.
65. LS Costanzo and EE Windhager (1980) Effect of PTH, ADH and cAMP on distal tubular Ca and Na reabsorption. Am J Physiol 239 F478-F485.
66. LS Costanzo (1984) Comparison of calcium and sodium transport in early and late rat distal tubules: effect of amiloride. Am J Physiol 246 F937-F945.
67. JL Borke, A Caride, AK Verma, et al. (1989) Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules. Am J Physiol 257 F842-F849.
68. C Ramachandran and MG Brunette (1989) The renal Na+/Ca++ exchange system is located exclusively in the distal tubule. Biochem J 257 259-264.
69. RF Reilly and DH Ellison (2000) Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev 80 277-313. [Review] [304 refs]
70. JG Hoenderop, A Hartog, M Stuiver, et al. (2000) Localization of the epithelial Ca(2+) channel in rabbit kidney and intestine. J Am Soc Nephrol 11 1171-1178.
71. SN Kip and EE Strehler (2003) Characterization of PMCA isoforms and their contribution to transcellular Ca2+ flux in MDCK cells. Am J Physiol Renal Physiol 284 F122-F132.
72. J Loffing and B Kaissling (2003) Sodium and calcium transport pathways along the mammalian distal nephron: from rabbit to human. Am J Physiol Renal Physiol 284 F628-F643. [Review] [142 refs]
73. T Shimizu, K Yoshitomi, N Nakamura, et al. (1990) Effects of PTH, calcitonin, and cAMP on calcium transport in rabbit distal nephron segments. Am J Physiol 259 F408-F414.
74. RJ Bindels, A Hartog, J Timmermans, et al. (1991) Active Ca2+ transport in primary cultures of rabbit kidney CCD: stimulation by 1,25-dihydroxyvitamin D3 and PTH. Am J Physiol 261 F799-F807.
75. JG Hoenderop, JP van Leeuwen, BC van der Eerden, et al. (2003) Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J Clin Invest 112 1906-1914.
76. CT Lee, VM Huynh, LW Lai, et al. (2002) Cyclosporine A-induced hypercalciuria in calbindin-D28k knockout and wild-type mice. Kidney Int 62 2055-2061.
77. BJ Bacskai and PA Friedman (1990) Activation of latent Ca2+ channels in renal epithelial cells by parathyroid hormone. Nature 347 388-391.
78. IV Silva, V Cebotaru, H Wang, et al. (2003) The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res 18 615-623.
79. EI Christensen, O Devuyst, G Dom, et al. (2003) Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci U S A 100 8472-8477.
80. FH Epstein (1968) Calcium and the kidney. Am J Med 45 700-715.
81. S Torikai, M-S Wang, KL Klein, et al. (1981) Adenylate cyclase and cell cyclic AMP of rat cortical thick ascending limb of Henle. Kidney Int 20 649-654.
82. OLM Bijvoet (1977) Kidney function in calcium and phosphate metabolism. LV Avioli, SM Krane,(Eds) Metabolic Bone Disease vol 1 New York: Academic Press 49-140.
83. M Peacock, WG Robertson and BEC Nordin (1969) Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet 1 384-386.
84. GR Shareghi and LC Stoner (1978) Calcium transport across segments of the rabbit distal nephron in vitro. Am J Physiol 235 F367-F375.
85. WN Suki and D Rouse (1981) Hormonal regulation of calcium transport in thick ascending limb renal tubules. Am J Physiol 241 F171.
86. C Hemmingsen (2000) Regulation of renal calbindin-D28k. Pharmacol Toxicol 87 5-30. [Review] [163 refs]
87. A Jayakumar, L Cheung, CT Liang, et al. (1984) Sodium gradient-dependent calcium uptake in renal basolateral membrane vesicles. J Biol Chem 259 10827-10833.
88. K Bomsztyk, JP George and FS Wright (1984) Effects of luminal fluid anions on calcium transport by proximal tubule. Am J Physiol 246 F600-F608.
89. JE Scoble, S Mills and KA Hruska (1985) Calcium transport in canine renal basolateral membrane vesicles, effect of parathyroid hormones. J Clin Invest 75 1096-1105.
90. I Bouhtiauy, D LaJeunesse and MG Brunette (1991) The mechanism of parathyroid hormone action on calcium reabsorption by the distal tubule. Endocrinology 128 251-258.
91. T Shimizu, M Nakamura, K Yoshitomi, et al. (1991) Interaction of trichlormethiazide or amiloride with PTH in stimulating Ca2+ absorption in rabbit CNT. Am J Physiol 261 F36-F43.
92. Y Tsukamoto, S Saka and M Saitoh (1992) Parathyroid hormone stimulates ATP-dependent calcium pump activity by a different mode in proximal and distal tubules of the rat. Biochim Biophys Acta 1103 163-171.
93. FA Gesek and PA Friedman (1992) On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells. J Clin Invest 90 749-758.
94. JG Hoenderop, B Nilius and RJ Bindels (2002) Molecular mechanism of active Ca2+ reabsorption in the distal nephron. Ann Rev Physiol 64 529-549. [Review] [85 refs]
95. J Taniguchi, M Takeda, K Yoshitomi, et al. (1994) Pressure- and parathyroid-hormone-dependent Ca2+ transport in rabbit connecting tubule: role of the stretch-activated nonselective cation channel. J Membr Biol 140 123-132.
96. C de Rouffignac, A DiStefano, M Wittner, et al. (1991) Consequences of differential effects of ADH and other peptide hormones on thick ascending limb of mammalian kidney. Am J Physiol 260 R1023-R1035.
97. SC Hebert (1996) Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 50 2129-2139.
98. L Even, Y Weisman, D Goldray, et al. (1996) Selective modulation by vitamin D of renal response to parathyroid hormone: a study in calcitriol-resistant rickets. J Clin Endocrinol Metab 81 2836-2840.
99. PA Friedman and FA Gesek (1993) Calcium transport in renal epithelial cells. Am J Physiol 264 F181-F198.
100. LS Costanzo, PR Sheehe and IM Weiner (1974) Renal actions of vitamin D in D-deficient rats. Am J Physiol 226 1490-1495.
101. S Christakos, C Gabrielides and WB Rhoten (1989) Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations, and molecular biology. Endocr Rev 10 3-26. [Review] [251 refs]
102. J Van Baal, A Yu, A Hartog, et al. (1996) Localization and regulation by vitamin D of calcium transport proteins in rabbit cortical collecting system. Am J Physiol 271 F985-F993.
103. JG Hoenderop, D Muller, AW Van Der Kemp, et al. (2001) Calcitriol controls the epithelial calcium channel in kidney. J Am Soc Nephrol 12 1342-1349.
104. FR Singer, NJ Woodhouse, DK Parkinson, et al. (1969) Some acute effects of administered porcine calcitonin in man. Clin Sci 37 181-190.
105. JJ Chipman, J Zerwekh, M Nicar, et al. (1980) Effect of growth hormone administration: reciprocal changes in serum 1a,25-dihydroxyvitamin D and intestinal calcium absorption. J Clin Endocrinol Metab 51 321-324.
106. JM Gertner, WV Tamborlane, RL Hintz, et al. (1981) The effects on mineral metabolism of overnight growth hormone infusion in growth hormone deficiency. J Clin Endocrinol Metab 53 818-822.
107. NM Wright, N Papadea, B Wentz, et al. (1997) Increased serum 1,25-dihydroxyvitamin D after growth hormone administration is not parathyroid hormone-mediated. Calcif Tissue Int 61 101-103.
108. TJ Hahn, LR Halstead and DT Baran (1981) Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 52 111-114.
109. J Lemann Jr, WF Piering and EJ Lennon (1970) Studies of the acute effects of aldosterone and cortisol on the interrelationship between renal sodium, calcium and magnesium excretion in normal man. Nephron 7 117-130.
110. JW Findley, ND Adams, J Lemann Jr, et al. (1982) Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis. J Clin Endocrinol Metab 54 1039-1044.
111. JC Gallagher and BEC Nordin (1972) Treatment with oestrogens of primary hyperparathyroidism in post-menopausal women. Lancet 1 503-507.
112. W McKane, S Khosla, M Burritt, et al. (1995) Mechanism of renal calcium conservation with estrogen replacement therapy in women in early menopause—a clinical research center study. J Clin Endocrinol Metab 80 3458-3464.
113. M Van Abel, JG Hoenderop, O Dardenne, et al. (2002) 1,25-dihydroxyvitamin D(3)-independent stimulatory effect of estrogen on the expression of ECaC1 in the kidney. J Am Soc Nephrol 13 2102-2109.
114. RA DeFronzo, CR Cooke, R Andres, et al. (1975) The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in man. J Clin Invest 55 845-853.
115. A Charbonneau, M Leclerc and MG Brunette (2001) Effect of angiotensin II on calcium reabsorption by the luminal membranes of the nephron. Am J Physiol Endocrinol Metab 280 E928-36.
116. SL Naylor, AU Sakaguchi, P Szoka, et al. (1983) Human parathyroid hormone gene (PTH) is on short arm of chromosome 11, Somat Cell. Gene 9 609-616.
117. T Vasicek, BE McDevitt, MW Freeman, et al. (1983) Nucleotide sequence of genomic DNA encoding human parathyroid hormone. Proc Natl Acad Sci U S A 80 2127-2131.
118. T Okazaki, T Igarashi and HM Kronenberg (1989) 5′-Flanking region of the parathyroid hormone gene mediates negative regulation by 1,25(OH)2 vitamin D3. J Biol Chem 263 2203-2208.
119. MB Demay, MS Kiernan, HF DeLuca, et al. (1992) Sequences in the human parathyroid hormone gene that bind the 1,25- dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A 89 8097-8101.
120. T Naveh-Many, R Rahaminov, N Livini, et al. (1995) Parathyroid cell proliferation in normal and chronic renal failure in rats, the effects of calcium, phosphate, and vitamin D. J Clin Invest 96 1786-1793.
121. Y Almaden, A Canalejo, A Hernandez, et al. (1996) Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 11 970-976.
122. J Russell, D Lettieri and LM Sherwood (1983) Direct regulation by calcium of cytoplasmic messenger ribonucleic acid coding for pre-proparathyroid hormone in isolated bovine parathyroid cells. J Clin Invest 72 1851-1855.
123. T Naveh-Many, MM Friedlaender, H Mayer, et al. (1989) Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat, Dominant role of 1,25-dihydroxyvitamin D. Endocrinology 125 275-280.
124. B Kemper, JF Habener, RC Mulligan, et al. (1974) Preproparathyroid hormone: a direct translation product of parathyroid messenger RNA. Proc Natl Acad Sci U S A 71 3731-3735.
125. H Jüppner, AB Abou-Samra, MW Freeman, et al. (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254 1024-1026.
126. AB Abou-Samra, H Jüppner, T Force, et al. (1992) Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A 89 2732-2736.
127. L Gelbert, E Schipani, H Jüppner, et al. (1994) Chromosomal location of the parathyroid hormone/parathyroid hormone-related protein receptor gene to human chromosome 3p21.2–p24.2. J Clin Endocrinol Metab 79 1046-1048.
128. Z Pausova, J Bourdon, D Clayton, et al. (1994) Cloning of a parathyroid hormone/parathyroid hormone-related peptide receptor (PTHR) cDNA from a rat osteosarcoma (UMR106) cell line: chromosomal assignment of the gene in the human, mouse, and rat genomes. Genomics 20 20-26.
129. H Jüppner, T Gardella, E Brown, et al. (2000) Parathyroid hormone and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development. L DeGroot, J Jameson,(Eds) Endocrinology W.B. Saunders Company: Philadelphia, PA 969-998.
130. H Kronenberg (2003) Developmental regulation of the growth plate. Nature 423 332-336.
131. RV Thakker (1996) Molecular genetics of parathyroid disease. Curr Opin Endocrinol Diabetes Obes 3 521-528.
132. J Szabo, B Heath, VM Hill, et al. (1995) Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56 944-950.
133. A Arnold, MF Brown, P Urena, et al. (1995) Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95 2047-2053.
134. A Arnold, HG Kim, RD Gaz, et al. (1989) Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 83 2034-2040.
135. T Motokura, T Bloom, HG Kim, et al. (1991) A BCL1-linked candidate oncogene which is rearranged in parathyroid tumors encodes a novel cyclin. Nature 350 512-515.
136. P Nurse (1990) Universal control mechanism regulating onset of M-phase. Nature 344 503-508.
137. Y Hosokawa, K Yoshimoto, R Bronson, et al. (1997) Chronic hyperparathyroidism in transgenic mice with parathyroid-targeted overexpression of cyclin D1/PRAD1. J Bone Miner Res 12(suppl 1), S110.
138. Y Imanishi, Y Hosokawa, K Yoshimoto, et al. (2001) Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 107 1093-1102.
139. TC Wang, RD Cardiff, L Zukerberg, et al. (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 669-671.
140. AY Au, K McDonald, A Gill, et al. (2008) PTH mutation with primary hyperparathyroidism and undetectable intact PTH. N Engl J Med 359 1184-1186.
141. RV Thakker (1993) The molecular genetics of the multiple endocrine neoplasia syndromes. Clin Endocrinol (Oxf) 38 1-14.
142. D Trump, B Farren, C Wooding, et al. (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 89 653-669.
143. S Marx (1998) Multiple endocrine neoplasia type 1. B Vogelstein, K Kinzler,(Eds) The genetic basis of human cancer New York: McGraw Hill 489-506.
144. RV Thakker (1998) Multiple endocrine neoplasia–syndromes of the twentieth century. J Clin Endocrinol Metab 83 2617-2620.
145. SC Chandrasekharappa, SC Guru, P Manickam, et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 404-407.
146. I Lemmens, WJ Van de Ven, K Kas, et al. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1, Hum Mol Genet 6 1177-1183.
147. AA Pannett and RV Thakker (1999) Multiple endocrine neoplasia type 1. Endocr Relat Cancer 6 449-473.
148. MC Lemos and RV Thakker (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29 22-32.
149. JJ Turner, PD Leotlela, AA Pannett, et al. (2002) Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 87 2688-2693.
150. JH Bassett, SA Forbes, AA Pannett, et al. (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 62 232-244.
151. BT Teh, S Kytola, F Farnebo, et al. (1998) Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 83 2621-2626.
152. C Heppner, MB Kester, SK Agarwal, et al. (1997) Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16 375-378.
153. Z Zhuang, AO Vortmeyer, S Pack, et al. (1997) Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57 4682-4686.
154. Z Zhuang, SZ Ezzat, AO Vortmeyer, et al. (1997) Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 57 5446-5451.
155. TR Prezant, J Levine and S Melmed (1998) Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors. J Clin Endocrinol Metab 83 1388-1391.
156. LV Debelenko, E Brambilla, SK Agarwal, et al. (1997) Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6 2285-2290.
157. AO Vortmeyer, R Boni, E Pak, et al. (1998) Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas. J Natl Cancer Inst 90 398-399.
158. F Farnebo, BT Teh, S Kytola, et al. (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 83 2627-2630.
159. T Carling, P Correa, O Hessman, et al. (1998) Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab 83 2960-2963.
160. C Tanaka, T Kimura, P Yang, et al. (1998) Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas. J Clin Endocrinol Metab 83 2631-2634.
161. AA Pannett and RV Thakker (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson “two-hit” hypothesis. J Clin Endocrinol Metab 86 4371-4374.
162. BT Teh, CT Esapa, R Houlston, et al. (1998) A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. Am J Hum Genet 63 1544-1549.
163. AA Pannett, AM Kennedy, JJ Turner, et al. (2003) Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) 58 639-646.
164. FM Hannan, MA Nesbit, PT Christie, et al. (2008) Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene. Nat Clin Pract Endocrinol Metab 4 53-58.
165. SY Lin and SJ Elledge (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113 881-889.
166. P Stalberg, P Grimfjard, M Santesson, et al. (2004) Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1. J Clin Endocrinol Metab 89 2326-2337.
167. YS Kim, AL Burns, PK Goldsmith, et al. (1999) Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18 5936-5942.
168. W Yumita, Y Ikeo, K Yamauchi, et al. (2003) Suppression of insulin-induced AP-1 transactivation by menin accompanies inhibition of c-Fos induction. Int J Cancer 103 738-744.
169. N Hussein, H Casse, S Fontaniere, et al. (2007) Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis. Eur J Cancer 43 402-414.
170. LM Mulligan, JBJ Kwok, CS Healey, et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363 458-460.
171. LM Mulligan and BA Ponder (1995) Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 80 1989-1995.
172. Z Pausova, N Janicic, EM Konrad, et al. (1994) Analysis of the RET proto-oncogene in sporadic parathyroid tumors. J Bone Mineral Research 9 S151.
173. BC Padberg, S Schroder, W Jochum, et al. (1995) Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am J Pathol 147 1600-1607.
174. HM Heshmati, H Gharib, S Khosla, et al. (1997) Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significance. Mayo Clin Proc 72 430-436.
175. S Kennett and H Pollick (1971) Jaw lesions in familial hyperparathyroidism. Oral Surg Oral Med Oral Pathol 31 502-510.
176. CE Jackson, RA Norum, SB Boyd, et al. (1990) Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108 1006-1012.
177. KJ Bradley, MR Hobbs, ID Buley, et al. (2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med 257 18-26.
178. BM Cavaco, L Barros, AA Pannett, et al. (2001) The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred. QJM 94 213-222.
179. WS Wassif, CF Moniz, E Friedman, et al. (1993) Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 77 1485-1489.
180. C Williamson, BM Cavaco, A Jauch, et al. (1999) Mapping the gene causing hereditary primary hyperparathyroidism in a Portuguese kindred to chromosome 1q22-q31. J Bone Miner Res 14 230-239.
181. LS Weinstein and WF Simonds (2003) HRPT2, a marker of parathyroid cancer. N Engl J Med 349 1691-1692.
182. JD Carpten, CM Robbins, A Villablanca, et al. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32 676-680.
183. TM Shattuck, S Valimaki, T Obara, et al. (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349 1722-1729.
184. VM Howell, CJ Haven, K Kahnoski, et al. (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40 657-663.
185. KJ Bradley, BM Cavaco, MR Bowl, et al. (2006) Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxf) 64 299-306.
186. F Cetani, E Pardi, E Ambrogini, et al. (2006) Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management. Clin Endocrinol (Oxf) 64 146-152.
187. LJ Krebs, TM Shattuck and A Arnold (2005) HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab 90 5015-5017.
188. J Zhao, A Yart, S Frigerio, et al. (2007) Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene. Oncogene 26 3440-3449.
189. HC Zheng, H Takahashi, XH Li, et al. (2008) Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Virchows Arch 452 147-155.
190. S Selvarajan, LH Sii, A Lee, et al. (2008) Parafibromin expression in breast cancer: a novel marker for prognostication? J Clin Pathol 61 64-67.
191. KJ Bradley, MR Bowl, SE Williams, et al. (2007) Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal. Oncogene 26 1213-1221.
192. O Rozenblatt-Rosen, CM Hughes, SJ Nannepaga, et al. (2005) The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25 612-620.
193. A Yart, M Gstaiger, C Wirbelauer, et al. (2005) The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 25 5052-5060.
194. C Mosimann, G Hausmann and K Basler (2006) Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. Cell 125 327-341.
195. P Wang, MR Bowl, S Bender, et al. (2008) Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice. Mol Cell Biol 28 2930-2940.
196. P Bjorklund, G Akerstrom and G Westin (2007) Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors. J Clin Endocrinol Metab 92 338-344.
197. P Bjorklund, G Akerstrom and G Westin (2007) An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling. PLoS Med 4 e328.
198. P Bjorklund, D Lindberg, G Akerstrom, et al. (2008) Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients. Mol Cancer 7 53.
199. J Costa-Guda and A Arnold (2007) Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. J Clin Endocrinol Metab 92 1564-1566.
200. S Ikeda, Y Ishizaki, Y Shimizu, et al. (2002) Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas. Int J Oncol 20 463-466.
201. RA Weinberg (1991) Tumor suppressor genes. Science 254 1138-1146.
202. VL Cryns, A Thor, HJ Xu, et al. (1994) Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma. New Engl J Med 330 757-761.
203. SH Pearce, D Trump, C Wooding, et al. (1996) Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours. Clin Endocrinol (Oxf) 45 195-200.
204. T Carling, Y Du, W Fang, et al. (2003) Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas. Surgery 134 932-939.
205. L Pei, S Melmed, B Scheithauer, et al. (1995) Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55 1613-1616.
206. VL Cryns, SM Yi, H Tahara, et al. (1995) Frequent loss of chromosomes arm 1p DNA in parathyroid adenomas. Genes Chromosomes & Cancer 13 9-17.
207. C Williamson, AA Pannett, JT Pang, et al. (1997) Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36. J Med Genet 34 617-619.
208. EM Brown and RJ MacLeod (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81 239-297.
209. WF Simonds, LA James-Newton, SK Agarwal, et al. (2002) Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81 1-26.
210. WF Simonds, CM Robbins, SK Agarwal, et al. (2004) Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89 96-102.
211. JV Warner, DR Nyholt, F Busfield, et al. (2006) Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3–14. J Med Genet 43 e12.
212. MR Pollak, EM Brown, YH WuChou, et al. (1993) Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75 1297-1303.
213. YH Chou, MR Pollak, ML Brandi, et al. (1995) Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet 56 1075-1079.
214. S Pearce, D Trump, C Wooding, et al. (1995) Calcium-sensing receptor mutations in familial benign hypercalcaemia and neonatal hyperparathyroidism. J Clin Invest 96 2683-2692.
215. N Janicic, Z Pausova, DE Cole, et al. (1995) Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet 56 880-886.
216. K Aida, S Koishi, M Inoue, et al. (1995) Familial hypocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene. J Clin Endocrinol Metab 80 2594-2598.
217. H Heath III, S Odelberg, CE Jackson, et al. (1996) Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 81 1312-1317.
218. N Janicic, E Soliman, Z Pausova, et al. (1995) Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mamm Genome 6 798-801.
219. KJ Morten, JM Cooper, GK Brown, et al. (1993) A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 2 2081-2087.
220. SH Pearce, M Bai, SJ Quinn, et al. (1996) Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest 98 1860-1866.
221. M Bai, S Quinn, S Trivedi, et al. (1996) Expression and characterization of inactivating and activating mutations in the human Ca2+-sensing receptor. J Biol Chem 271 19537-19545.
222. MR Pollak, YH Chou, SJ Marx, et al. (1994) Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, Effects of mutant gene dosage on phenotype. J Clin Invest 93 1108-1112.
223. M Bai, SH Pearce, O Kifor, et al. (1997) In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99 88-96.
224. H Heath III, CE Jackson, B Otterrud, et al. (1993) Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 53 193-200.
225. CT McMurtry, FW Schranck, DA Walkenhorst, et al. (1992) Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia. Am J Med 93 247-258.
226. D Trump, MP Whyte, C Wooding, et al. (1995) Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH. Hum Genet 96 183-187.
227. SE Lloyd, AA Pannett, PH Dixon, et al. (1999) Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. Am J Hum Genet 64 189-195.
228. O Kifor, FD Moore Jr, M Delaney, et al. (2003) A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 88 60-72.
229. H Jüppner, E Schipani and C Silve (2002) Jansen's metaphyseal chondrodysplasia and Blomstrand's lethal chondrodysplasia: two genetic disorders caused by PTH/PTHrP receptor mutations. J Bilezikian, L Raisz, G Rodan,(Eds) Principles of bone biology San Diego, CA: Academic Press 1117-1135.
230. E Schipani, K Kruse and H Jüppner (1995) A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268 98-100.
231. E Schipani, CB Langman, AM Parfitt, et al. (1996) Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. New Engl, J Med 335 708-714.
232. E Schipani, CB Langman, J Hunzelman, et al. (1999) A novel PTH/PTHrP receptor mutation in Jansen's metaphyseal chondrodysplasia. J Clin Endocrinol Metab 84 3052-3057.
233. E Schipani, B Lanske, J Hunzelman, et al. (1997) Targeted expression of constitutively active PTH/PTHrP receptors delays endochondral bone formation and rescues PTHrP-less mice. Proc Natl Acad Sci U S A 94 13689-13694.
234. M Bastepe, A Raas-Rothschild, J Silver, et al. (2004) A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating PTH/PTHrP receptor mutation. J Clin Endocrinol Metab 89 3595-3600.
235. E Schipani, GS Jensen, J Pincus, et al. (1997) Constitutive activation of the cAMP signaling pathway by parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia. Mol Endocrinol 11 851-858.
236. AK Ewart, CA Morris, DL Atkinson, et al. (1993) Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nature Genet 5 11-16.
237. E Nickerson, F Greenberg, MT Keating, et al. (1995) Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet 56 1156-1161.
238. MC Lowery, CA Morris, A Ewart, et al. (1995) Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients. Am J Hum Genet 57 49-53.
239. D Li, B Brooke, E Davis, et al. (1998) Elastin is an essential determinant of arterial morphogenesis. Nature 393 276-280.
240. M Tassabehji, K Metcalfe, WD Fergusson, et al. (1996) LIM-kinase deleted in Williams syndrome. Nat Genet 13 272-273.
241. LA Perez Jurado, X Li and U Francke (1995) The human calcitonin receptor gene (CALCR) at 7q21.3 is outside the deletion associated with the Williams syndrome. Cytogenet Cell Genet 70 246-249.
242. A Arnold, SA Horst, TJ Gardella, et al. (1990) Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest 86 1084-1087.
243. AC Karaplis, SK Lim, H Baba, et al. (1995) Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant preproparathyroid hormone protein. J Biol Chem 270 1629-1635.
244. R Datta, A Waheed, GN Shah, et al. (2007) Signal sequence mutation in autosomal dominant form of hypoparathyroidism induces apoptosis that is corrected by a chemical chaperone. Proc Natl Acad Sci U S A 104 19989-19994.
245. T Sunthornthepvarakul, S Churesigaew and S Ngowngarmratana (1999) A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal-recessive familial isolated hypoparathyroidism. J Clin Endocrinol Metab 84 3792-3796.
246. D Parkinson and R Thakker (1992) A donor splice site mutation in the parathyroid hormone gene is associated with autosomal-recessive hypoparathyroidism. Nature Genet 1 149-153.
247. T Günther, ZF Chen, J Kim, et al. (2000) Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 406 199-203.
248. J Kim, B Jones, C Zock, et al. (1998) Isolation and characterization of mammalian homologs of the Drosophila gene glial cells missing. Proc Natl Acad Sci U S A 95 12364-12369.
249. Z Liu, S Yu and NR Manley (2007) Gcm2 is required for the differentiation and survival of parathyroid precursor cells in the parathyroid/thymus primordia. Dev Biol 305 333-346.
250. C Ding, B Buckingham and MA Levine (2001) Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest 108 1215-1220.
251. L Baumber, C Tufarelli, S Patel, et al. (2005) Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal-recessive familial isolated hypoparathyroidism. J Med Genet 42 443-448.
252. M Mannstadt, G Bertrand, M Muresan, et al. (2008) Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism. J Clin Endocrinol Metab 93 3568-3576.
253. V Peden (1960) True idiopathic hypoparathyroidism as a sex-linked recessive trait. Am J Human Genet 12 323-337.
254. M Whyte and V Weldon (1981) Idiopathic hypoparathyroidism presenting with seizures during infancy: X-linked recessive inheritance in a large Missouri kindred. J Pediatr 99 608-611.
255. M Whyte, G Kim and M Kosanovich (1986) Absence of parathyroid tissue in sex-linked recessive hypoparathyroidism. J Paediatr 109 915.
256. S Mumm, MP Whyte, RV Thakker, et al. (1997) mtDNA Analysis shows common ancestry in two kindreds with X-linked recessive hypoparathyroidism and reveals a heteroplasmic silent mutation. Am J Hum Genet 60 153-159.
257. RV Thakker, KE Davies, MP Whyte, et al. (1990) Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies. J Clin Invest 86 40-45.
258. M Bowl, M Nesbit, B Harding, et al. (2005) An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism. J Clin Invest 115 2822-2831.
259. NM Solomon, SA Ross, T Morgan, et al. (2004) Array comparative genomic hybridisation analysis of boys with X-linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J Med Genet 41 669-678.
260. K Rizzoti, S Brunelli, D Carmignac, et al. (2004) SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat Genet 36 247-255.
261. J Collignon, S Sockanathan, A Hacker, et al. (1996) A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 122 509-520.
262. DA Kleinjan and V van Heyningen (2005) Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 76 8-32.
263. S Brunelli, E Silva Casey, D Bell, et al. (2003) Expression of Sox3 throughout the developing central nervous system is dependent on the combined action of discrete, evolutionarily conserved regulatory elements. Genesis 36 12-24.
264. M Uchikawa, Y Ishida, T Takemoto, et al. (2003) Functional analysis of chicken Sox2 enhancers highlights an array of diverse regulatory elements that are conserved in mammals. Dev Cell 4 509-519.
265. AE Kiernan, AL Pelling, KK Leung, et al. (2005) Sox2 is required for sensory organ development in the mammalian inner ear. Nature 434 1031-1035.
266. M Stevanovic, R Lovell-Badge, J Collignon, et al. (1993) SOX3 is an X-linked gene related to SRY. Hum Mol Genet 2 2013-2018.
267. P Ahonen, S Myllarniemi, I Sipila, et al. (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322 1829-1836.
268. P Ahonen (1985) Autoimmune polyendocrinopathy–candidosis–ectodermal dystrophy (APECED): autosomal-recessive inheritance. Clin Genet 27 535-542.
269. J Zlotogora and MS Shapiro (1992) Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 29 824-826.
270. J Aaltonen, P Bjorses, L Sandkuijl, et al. (1994) An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet 8 83-87.
271. K Nagamine, P Peterson, HS Scott, et al. (1997) Positional cloning of the APECED gene. Nat Genet 17 393-398.
272. SH Pearce, T Cheetham, H Imrie, et al. (1998) A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet 63 1675-1684.
273. HS Scott, M Heino, P Peterson, et al. (1998) Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol 12 1112-1119.
274. MC Rosatelli, A Meloni, M Devoto, et al. (1998) A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 103 428-434.
275. P Bjorses, M Halonen, JJ Palvimo, et al. (2000) Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 66 378-392.
276. A Liston, S Lesage, J Wilson, et al. (2003) AIRE regulates negative selection of organ-specific T cells. Nat Immunol 4 350-354.
277. A Meager, K Visvalingam, P Peterson, et al. (2006) Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3 e289.
278. M Alimohammadi, P Bjorklund, A Hallgren, et al. (2008) Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358 1018-1028.
279. SC Eisenbarth, OR Colegio, W O’Connor, et al. (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453 1122-1126.
280. PJ Scambler, AH Carey, RK Wyse, et al. (1991) Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 10 201-206.
281. G Monaco, C Pignata, E Rossi, et al. (1991) DiGeorge anomaly associated with 10p deletion. Am J Med Genet 39 215-216.
282. W Gong, BS Emanuel, J Collins, et al. (1996) A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11. Hum Mol Genet 5 789-800.
283. PJ Scambler (2000) The 22q11 deletion syndromes. Hum Mol Genet 9 2421-2426.
284. S Augusseau, S Jouk, P Jalbert, et al. (1986) DiGeorge syndrome and 22q11 rearrangements. Hum Genet 74 206.
285. ML Budarf, J Collins, W Gong, et al. (1995) Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat Genet 10 269-278.
286. H Yamagishi, V Garg, R Matsuoka, et al. (1999) A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science 283 1158-1161.
287. EA Lindsay, A Botta, V Jurecic, S Carattini-Rivera, et al. (1999) Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401 379-383.
288. P Magnaghi, C Roberts, S Lorain, et al. (1998) HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3. Nat Genet 20 74-77.
289. LA Jerome and VE Papaioannou (2001) DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27 286-291.
290. H Yagi, Y Furutani, H Hamada, et al. (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362 1366-1373.
291. A Baldini (2003) DiGeorge's syndrome: a gene at last. Lancet 362 1342-1343.
292. G Scire, B Dallapiccola, P Iannetti, et al. (1994) Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions. Am J Med Genet 52 478-482.
293. K Sykes, L Bachrach, J Siegel-Bartelt, et al. (1997) Velocardiofacial syndrome presenting as hypocalcemia in early adolescence. Arch Pediatr Adolesc Med 151 745-747.
294. R Bilous, G Murty, D Parkinson, et al. (1992) Autosomal dominant familial hypoparathyroidism, sensorineural deafness and renal dysplasia. N Engl J Med 327 1069-1084.
295. H Van Esch, P Groenen, MA Nesbit, et al. (2000) GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406 419-422.
296. K Muroya, T Hasegawa, Y Ito, et al. (2001) GATA3 abnormalities and the phenotypic spectrum of HDR syndrome. J Med Genet 38 374-380.
297. MA Nesbit, MR Bowl, B Harding, et al. (2004) Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem 279 22624-22634.
298. A Ali, PT Christie, IV Grigorieva, et al. (2007) Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor. Hum Mol Genet 16 265-275.
299. AP Tsang, JE Visvader, CA Turner, et al. (1997) FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90 109-119.
300. A Zahirieh, MA Nesbit, A Ali, et al. (2005) Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Endocrinol Metab 90 2445-2450.
301. YS Dai and BE Markham (2001) p300 Functions as a coactivator of transcription factor GATA-4. J Biol Chem 276 37178-37185.
302. PP Pandolfi, ME Roth, A Karis, et al. (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 11 40-44.
303. J van der Wees, MA van Looij, MM de Ruiter, et al. (2004) Hearing loss following Gata3 haploinsufficiency is caused by cochlear disorder. Neurobiol Dis 16 169-178.
304. MA van Looij, H van der Burg, RS van der Giessen, et al. (2005) GATA3 haploinsufficiency causes a rapid deterioration of distortion product otoacoustic emissions (DPOAEs) in mice. Neurobiol Dis 20 890-897.
305. KC Lim, G Lakshmanan, SE Crawford, et al. (2000) Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat Genet 25 209-212.
306. D Grote, A Souabni, M Busslinger, et al. (2006) Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development 133 53-61.
307. CT Moraes, S DiMauro, M Zeviani, et al. (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 320 1293-1299.
308. ML Zupanc, CT Moraes, S Shanske, et al. (1991) Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol 29 680-683.
309. H Isotani, Y Fukumoto, H Kawamura, et al. (1996) Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNA deletion. Clin Endocrinol (Oxf) 45 637-641.
310. C Dionisi-Vici, B Garavaglia, AB Burlina, et al. (1996) Hypoparathyroidism in mitochondrial trifunctional protein deficiency. J Pediatr 129 159-162.
311. P Franceschini, A Testa, G Bogetti, et al. (1992) Kenny-Caffey syndrome in two sibs born to consanguineous parents: evidence for an autosomal recessive variant. Am J Med Genet 42 112-116.
312. JR Boynton, TR Pheasant, BL Johnson, et al. (1979) Ocular findings in Kenny's syndrome. Arch Ophthalmol 97 896-900.
313. RJ Richardson and JM Kirk (1990) Short stature, mental retardation, and hypoparathyroidism: a new syndrome. Arch Dis Child 65 1113-1117.
314. SA Sanjad, NA Sakati, YK Abu-Osba, et al. (1991) A new syndrome of congenital hypoparathyroidism, severe growth failure, and dysmorphic features. Arch Dis Child 66 193-196.
315. R Parvari, E Hershkovitz, A Kanis, et al. (1998) Homozygosity and linkage-disequilibrium mapping of the syndrome of congenital hypoparathyroidism, growth and mental retardation, and dysmorphism to a 1-cM interval on chromosome 1q42–43. Am J Hum Genet 63 163-169.
316. R Parvari, E Hershkovitz, N Grossman, et al. (2002) Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal-recessive Kenny-Caffey syndrome. Nat Genet 32 448-452.
317. D Parkinson, N Shaw, R Himsworth, et al. (1993) Parathyroid hormone gene analysis in autosomal hypoparathyroidism using an intragenic tetranucleotide (AAAT)n polymorphism. Hum Genet 91 281-284.
318. AY Barakat, JB D’Albora, MM Martin, et al. (1977) Familial nephrosis, nerve deafness, and hypoparathyroidism. J Pediatr 91 61-64.
319. PJ Dahlberg, WZ Borer, KL Newcomer, et al. (1983) Autosomal or X-linked recessive syndrome of congenital lymphedema, hypoparathyroidism, nephropathy, prolapsing mitral valve, and brachytelephalangy. Am J Med Genet 16 99-104.
320. MR Pollak, EM Brown, HL Estep, et al. (1994) Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation. Nat Genet 8 303-307.
321. DN Finegold, MM Armitage, M Galiani, et al. (1994) Preliminary localization of a gene for autosomal-dominant hypoparathyroidism to chromosome 3q13. Pediatr Res 36 414-417.
322. SH Pearce, C Williamson, O Kifor, et al. (1996) A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335 1115-1122.
323. J Baron, K Winer, J Yanovski, et al. (1996) Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 5 601-606.
324. R Okazaki, N Chikatsu, M Nakatsu, et al. (1999) A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. J Clin Endocrinol Metab 84 363-366.
325. RV Thakker (2000) Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome. Exp Nephrol 8 351-360.
326. SC Hebert (2003) Bartter syndrome. Curr Opin Nephrol Hypertens 12 527-532.
327. S Watanabe, S Fukumoto, H Chang, et al. (2002) Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360 692-694.
328. Y Li, YH Song, N Rais, et al. (1996) Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 97 910-914.
329. S Blomstrand, I Claësson and J Säve-Söderbergh (1985) A case of lethal congenital dwarfism with accelerated skeletal maturation, Pediatr. Radiol 15 141-143.
330. ID Young, JM Zuccollo and NJ Broderick (1993) A lethal skeletal dysplasia with generalised sclerosis and advanced skeletal maturation: Blomstrand chondrodysplasia. J Med Genet 30 155-157.
331. JG Leroy, G Keersmaeckers, M Coppens, et al. (1996) Blomstrand lethal chondrodysplasia. Am J Med Genet 63 84-89.
332. A Loshkajian, J Roume, V Stanescu, et al. (1997) Familial Blomstrand chondrodysplasia with advanced skeletal maturation: further delineation. Am J Med Genet 71 283-288.
333. NS den Hollander, HJ van der Harten, C Vermeij-Keers, et al. (1997) First-trimester diagnosis of Blomstrand lethal osteochondrodysplasia. Am J Med Genet 73 345-350.
334. RJ Oostra, B Baljet, PF Dijkstra, et al. (1998) Congenital anomalies in the teratological collection of museum Vrolik in Amsterdam, The Netherlands. II: skeletal dysplasia. Am J Med Genet 77 116-134.
335. AS Jobert, P Zhang, A Couvineau, et al. (1998) Absence of functional receptors parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 102 34-40.
336. P Zhang, AS Jobert, A Couvineau, et al. (1998) A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab 83 3365-3368.
337. AC Karaplis, MT Bin He, A Nguyen, et al. (1998) Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology 139 5255-5258.
338. MC Karperien, HJ van der Harten, R van Schooten, et al. (1999) A frame-shift mutation in the type I parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand lethal osteochondrodysplasia. J Clin Endocrinol Metab 84 3713-3720.
339. M Karperien, H Sips, H. Harten Hvd, et al. (2001) Novel mutations in the type I PTH/PTHrP receptor causing Blomstrand lethal osteochondrodysplasia (abstract). J Bone Mineral Res 16(Suppl 1), S549.
340. JJ Wysolmerski, S Cormier, W Philbrick, et al. (2001) Absence of functional type 1 PTH/PTHrP receptors in humans is associated with abnormal breast development and tooth impactation. J Clin Endocrinol Metab 86 1788-1794.
341. B Frame and AK Poznanski (1980) Conditions that may be confused with rickets. HF DeLuca, CS Anast,(Eds) Pediatric diseases related to calcium New York: Elsevier 269-289.
342. WHD De Haas, W De Boer and F Griffioen (1969) Metaphysial dysostosis. A late follow-up of the first reported case. J Bone Joint Surg 51B 290-299.